Cargando…
Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission
BACKGROUND: The World Health Organization (WHO) has set elimination (interruption of transmission) as an end goal for schistosomiasis. However, there is currently little guidance on the monitoring and evaluation strategy required once very low prevalence levels have been reached to determine whether...
Autores principales: | Toor, Jaspreet, Truscott, James E., Werkman, Marleen, Turner, Hugo C., Phillips, Anna E., King, Charles H., Medley, Graham F., Anderson, Roy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745786/ https://www.ncbi.nlm.nih.gov/pubmed/31522690 http://dx.doi.org/10.1186/s13071-019-3611-8 |
Ejemplares similares
-
The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni
por: Toor, Jaspreet, et al.
Publicado: (2018) -
Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination
por: Kura, Klodeta, et al.
Publicado: (2019) -
Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
por: Toor, Jaspreet, et al.
Publicado: (2020) -
The past matters: estimating intrinsic hookworm transmission intensity in areas with past mass drug administration to control lymphatic filariasis
por: Werkman, Marleen, et al.
Publicado: (2017) -
Defining stopping criteria for ending randomized clinical trials that investigate the interruption of transmission of soil-transmitted helminths employing mass drug administration
por: Werkman, Marleen, et al.
Publicado: (2018)